The State of Texas Attorney General Files Lawsuit Against Tylenol Manufacturers Over Autism Spectrum Assertions
Texas Attorney General Ken Paxton is filing a lawsuit against the makers of acetaminophen, alleging the firms concealed alleged dangers that the medication created to children's cognitive development.
This legal action arrives four weeks after Former President Trump advocated an unproven link between consuming Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in children.
The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which currently produces it.
In a declaration, he said they "deceived the public by making money from discomfort and marketing drugs without regard for the risks."
The manufacturer asserts there is insufficient reliable data tying Tylenol to autism spectrum disorder.
"These manufacturers deceived for years, knowingly endangering countless individuals to boost earnings," the attorney general, from the Republican party, declared.
Kenvue said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the well-being of US mothers and children."
On its online platform, Kenvue also stated it had "consistently assessed the applicable studies and there is insufficient valid information that shows a established connection between using acetaminophen and autism."
Organizations representing physicians and healthcare providers concur.
The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address pain and elevated temperature, which can pose significant medical dangers if ignored.
"In over twenty years of research on the consumption of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of acetaminophen in any trimester of gestation causes neurodevelopmental disorders in young ones," the association commented.
The lawsuit mentions latest statements from the previous government in asserting the drug is allegedly unsafe.
Recently, Trump caused concern from public health officials when he advised expectant mothers to "struggle intensely" not to consume Tylenol when ill.
Federal regulators then published an announcement that medical professionals should consider limiting the use of Tylenol, while also stating that "a direct connection" between the medication and autism spectrum disorder in minors has remains unverified.
Health Secretary Kennedy, who supervises the FDA, had pledged in spring to conduct "comprehensive study program" that would identify the cause of autism in a short period.
But experts warned that discovering a unique factor of autism - considered by experts to be the result of a intricate combination of inherited and surrounding conditions - would not be simple.
Autism is a form of enduring cognitive variation and condition that affects how individuals perceive and relate to the environment, and is identified using doctors' observations.
In his court filing, Paxton - aligned with the former president who is seeking the Senate - claims the manufacturer and J&J "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism spectrum disorder.
The case aims to force the corporations "remove any marketing or advertising" that states acetaminophen is reliable for expectant mothers.
The court case echoes the concerns of a collection of mothers and fathers of children with autism and attention deficit hyperactivity disorder who sued the makers of Tylenol in 2022.
A federal judge rejected the lawsuit, stating research from the plaintiffs' authorities was not conclusive.